Abstract
Objectives
Although abnormal expression of early growth response-1 (Egr1) has been revealed in various human solid tumors, the functions and potential mechanisms of Egr1 in the progression of salivary gland pleomorphic adenoma (SGPA) are not entirely understood.
Results
An elevated expression of Egr1 was observed both in the human salivary gland pleomorphic adenoma tissues and tumor-initiating cell (TIC) cells, when compared with control group. By loss-of-function assay, the proliferation and invasion capacities of TICs were inhibited, while the cell apoptosis was promoted, which were further evidenced by the protein expression analysis of several key apoptosis-related regulators. Furthermore, TICs with Mithramycin A (an Egr1 inhibitor) treatment achieved the same effects of endogenous Egr1 knockdown.
Conclusions
All these data collectively suggest that Egr1 act as an oncogenic factor in salivary gland pleomorphic adenoma, which may be a potential target for the treatment of SGPA.
Similar content being viewed by others
References
Ahmed MM (2004) Regulation of radiation-induced apoptosis by early growth response-1 gene in solid tumors. Curr Cancer Drug Targets 4:43–52
Ahmed MM et al (1996) EGR-1 induction is required for maximal radiosensitivity in A375-C6 melanoma cells. J Biol Chem 271:29231–29237. https://doi.org/10.1074/jbc.271.46.29231
Ahmed MM et al (1997) Ionizing radiation-inducible apoptosis in the absence of p53 linked to transcription factor EGR-1. J Biol Chem 272:33056–33061. https://doi.org/10.1074/jbc.272.52.33056
Chen ZH et al (2008) Egr-1 regulates autophagy in cigarette smoke-induced chronic obstructive pulmonary disease. PLoS ONE 3:e3316. https://doi.org/10.1371/journal.pone.0003316
Chen DG et al (2017) Inhibition of EGR1 inhibits glioma proliferation by targeting CCND1 promoter. J Exp Clin Cancer Res 36:186. https://doi.org/10.1186/s13046-017-0656-4
Kobayashi D et al (2002) Overexpression of early growth response-1 as a metastasis-regulatory factor in gastric cancer. Anticancer Res 22:3963–3970
Lei T, Zhu X, Zhu K, Jia F, Li S (2019) EGR1-induced upregulation of lncRNA FOXD2-AS1 promotes the progression of hepatocellular carcinoma via epigenetically silencing DKK1 and activating Wnt/beta-catenin signaling pathway. Cancer Biol Ther 20:1007–1016. https://doi.org/10.1080/15384047.2019.1595276
Li L et al (2019) EGR1 regulates angiogenic and osteoclastogenic factors in prostate cancer and promotes metastasis. Oncogene. https://doi.org/10.1038/s41388-019-0873-8
Liu HT, Liu S, Liu L, Ma RR, Gao P (2018) EGR1-mediated transcription of lncRNA-HNF1A-AS1 promotes cell-cycle progression in gastric cancer. Cancer Res 78:5877–5890. https://doi.org/10.1158/0008-5472.can-18-1011
Mohamad T, Kazim N, Adhikari A, Davie JK (2018) EGR1 interacts with TBX2 and functions as a tumor suppressor in rhabdomyosarcoma. Oncotarget 9:18084–18098. https://doi.org/10.18632/oncotarget.24726
Oben KZ et al (2017) Radiation induced apoptosis of murine bone marrow cells is independent of early growth response 1 (EGR1). PLoS ONE 12:e0169767. https://doi.org/10.1371/journal.pone.0169767
Pagel JI, Deindl E (2012) Disease progression mediated by egr-1 associated signaling in response to oxidative stress. Int J Mol Sci 13:13104–13117. https://doi.org/10.3390/ijms131013104
Shen S et al (2011) Tumor-initiating cells are enriched in CD44(hi) population in murine salivary gland tumor. PLoS ONE 6:e23282. https://doi.org/10.1371/journal.pone.0023282
Shen J et al (2019) MiR-150-5p retards the progression of myocardial fibrosis by targeting EGR1. Cell Cycle 18:1335–1348. https://doi.org/10.1080/15384101.2019.1617614
Shi B et al (2019) Upregulation of long noncoding RNA TUG1 by EGR1 promotes adenomyotic epithelial cell migration and invasion through recruiting EZH2 and suppressing TIMP2. Mol Reprod Dev 86:239–247. https://doi.org/10.1002/mrd.23099
Van Opdenbosch N, Lamkanfi M (2019) Caspases in cell death, inflammation, and disease. Immunity 50:1352–1364. https://doi.org/10.1016/j.immuni.2019.05.020
Walensky LD (2019) Targeting BAX to drug death directly. Nat Chem Biol 15:657–665. https://doi.org/10.1038/s41589-019-0306-6
Wang Y et al (2013) Opposing functions of PLAG1 in pleomorphic adenoma: a microarray analysis of PLAG1 transgenic mice. Biotechnol Lett 35:1377–1385. https://doi.org/10.1007/s10529-013-1213-7
Wang C et al (2015) EGR-1/Bax pathway plays a role in vitamin E delta-tocotrienol-induced apoptosis in pancreatic cancer cells. J Nutr Biochem 26:797–807. https://doi.org/10.1016/j.jnutbio.2015.02.008
Wu MY, Liang YR, Wu XY, Zhuang CX (2002) Relationship between Egr-1 gene expression and apoptosis in esophageal carcinoma and precancerous lesions. World J Gastroenterol 8:971–975. https://doi.org/10.3748/wjg.v8.i6.971
Xie B, Wang C, Zheng Z, Song B, Ma C, Thiel G, Li M (2011) Egr-1 transactivates Bim gene expression to promote neuronal apoptosis. J Neurosci 31:5032–5044. https://doi.org/10.1523/JNEUROSCI.5504-10.2011
Xu WL et al (2017) In situ release of VEGF enhances osteogenesis in 3D porous scaffolds engineered with osterix-modified adipose-derived stem cells. Tissue Eng Part A 23:445–457. https://doi.org/10.1089/ten.TEA.2016.0315
Xu W, Liu L, Lu H, Fu J, Zhang C, Yang W, Shen S (2019) Dysregulated long noncoding RNAs in pleomorphic adenoma tissues of pleomorphic adenoma gene 1 transgenic mice. Mol Med Rep 19:4735–4742. https://doi.org/10.3892/mmr.2019.10149
Yan L, Wang Y, Liang J, Liu Z, Sun X, Cai K (2017) MiR-301b promotes the proliferation, mobility, and epithelial-to-mesenchymal transition of bladder cancer cells by targeting EGR1. Biochem Cell Biol 95:571–577. https://doi.org/10.1139/bcb-2016-0232
Yoon TM et al (2015) EGR1 regulates radiation-induced apoptosis in head and neck squamous cell carcinoma. Oncol Rep 33:1717–1722. https://doi.org/10.3892/or.2015.3747
Yu Q, Huang Q, Du X, Xu S, Li M, Ma S (2018) Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson’s disease. Exp Neurol 302:145–154. https://doi.org/10.1016/j.expneurol.2018.01.009
Zhang H et al (2014) EGR1 decreases the malignancy of human non-small cell lung carcinoma by regulating KRT18 expression. Sci Rep 4:5416. https://doi.org/10.1038/srep05416
Zhao DY, Jacobs KM, Hallahan DE, Thotala D (2015) Silencing Egr1 attenuates radiation-induced apoptosis in normal tissues while killing cancer cells and delaying tumor growth. Mol Cancer Ther 14:2343–2352. https://doi.org/10.1158/1535-7163.MCT-14-1051
Zhao LY et al (2016) The overexpressed functional transient receptor potential channel TRPM2 in oral squamous cell carcinoma. Sci Rep 6:38471. https://doi.org/10.1038/srep38471
Zhong JT, Wang HJ, Yu J, Zhang JH, Wang SF, Yang X, Su W (2017) Correlations of the expressions of c-Jun and Egr-1 proteins with clinicopathological features and prognosis of patients with nasopharyngeal carcinoma. Cancer Biomark 19:213–220. https://doi.org/10.3233/CBM-161710
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81302359), Fundamental research program funding of Ninth People’s Hospital affiliated to Shanghai Jiao Tong University School of Medicine (JYZZ086B) and the 6th session of hospital outstanding Youth Funding of Ninth People’s Hospital affiliated to Shanghai Jiao Tong University School of Medicine.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Supporting information
Supplementary Table 1—The sequences used in this article.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Shen, S., Zhu, Y., Lu, H. et al. Transcription factor early growth response-1 plays an oncogenic role in salivary gland pleomorphic adenoma. Biotechnol Lett 42, 197–207 (2020). https://doi.org/10.1007/s10529-019-02776-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-019-02776-1